Stay up-to-date with the latest news and information from the drug testing industry by subscribing to Results, our monthly newsletter.
Your Privacy Choices | Privacy Notices | Privacy Shield | Terms | Language Assistance / Non-Discrimination Notice | Asistencia de Idiomas / Aviso de no Discriminación | 語言協助 / 不䈚視通知
Quest, Quest Diagnostics, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks — ® and ™ — are the property of their respective owners. © 2000-2023 Quest Diagnostics Incorporated. All rights reserved.
For people with chronic and reoccurring pain, prescription opioids – like Hydrocodone and Oxycodone – not only relieve suffering, but can help support a normal lifestyle. However, prescription opioids can be just as addictive and dangerous as illicit drugs.
While data from the Quest Diagnostics Drug Testing Index™ revealed recent positivity rate declines for prescription opiates, the increased misuse continues to be a growing concern. In fact, new data from the Centers for Disease Control and Prevention (CDC) shows that opioids were involved in more than 28,000 deaths in 2014.
To address this problem, President Obama announced his proposal to invest $1 billion in new mandatory funding over the next two years to expand access to treatment for prescription drug abuse. This funding will boost efforts to help individuals with an opioid use disorder seek treatment, successfully complete treatment and sustain recovery. Read the President’s announcement to see how these funds will be allocated to help combat this epidemic.
For more information about opiate testing, visit our website.